Serge Verreault, President and CEO of Crescita Therapeutics: New US Product Launch Coming Soon

TL;DR

Christina Therapeutics is a Canadian skincare company focused on developing innovative non-prescription and prescription products for the global market.

Transcript

this is Gabriel acoustic with an investing news network I'm here at bloom and Burton health care investing conference with Sir dwell roll and with Christina therapeutics thank you for being here today sir thank you very much give a yell ah wonderful so today I really want to learn more about Christina and you coming from a background working with o... Read More

Key Insights

• 🎯 Christina Therapeutics is a Canadian skincare company targeting both non-prescription and prescription skincare products.
• 🚀 The launch of their prescription product in the US market is a significant event for the company, offering great potential for growth.
• 🇵🇲 Their advanced technologies, like molecular enhancer penetration and pier technology, differentiate them from other skincare companies.
• 🧑‍💼 Christina Therapeutics aims to expand internationally by partnering with strategic distributors instead of establishing offices abroad.
• 🏘️ They have undergone reorganization and alignment of operations, focusing on in-house manufacturing and production partnerships.
• 🧘 The company has invested heavily in their growth and is now in a favorable financial position.
• 🌱 Their expansion plans include entering the Asian and US markets with their non-prescription products.

Questions & Answers

Q: What sets Christina Therapeutics apart from other skincare companies?

Christina Therapeutics stands out due to its advanced technologies like molecular enhancer penetration and pier technology, which are already being used in their products. These technologies enhance the effectiveness of their skincare solutions.

Q: How has Christina Therapeutics grown in the past few years?

Since its inception in 2016, Christina Therapeutics has undergone reorganization and alignment of operations, successfully setting the stage to become a commercial company. They have made strategic acquisitions and are now focusing on expanding their non-prescription products internationally.

Q: How does Christina Therapeutics plan to expand globally?

Rather than establishing offices in other countries, Christina Therapeutics aims to find strategic partners who can launch and distribute their products effectively. They seek business development partnerships to ensure a cost-effective and efficient expansion.

Q: What should investors know about Christina Therapeutics?

Over the past two years, Christina Therapeutics has invested in reorganizing and aligning their operations, transferring everything to their Montreal office. They also manufacture most of their products in-house and are expanding into production partnerships with other companies. Currently, they are in a favorable financial position to attract investors.

Summary & Key Takeaways

• Christina Therapeutics aims to make a significant impact in the Canadian market with their non-prescription and prescription skincare products.

• The company plans to grow organically and through business development initiatives, leveraging their expertise and technologies.

• 2018 and 2019 will bring major milestones, such as the launch of their prescription product in the US market and the expansion of their non-prescription products globally.